PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
266,000
+7,500 (2.90%)
Nov 17, 2026, 9:35 AM KST

PharmaResearch Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, PharmaResearch stock has a consensus rating of "Strong Buy" and an average price target of ₩427,733. The average 1-year stock price forecast is 60.80% higher than the current stock price, while the lowest is ₩324,000 (+21.80%) and the highest is ₩530,000 (+99.25%).

Price Target: ₩427,733 (+60.80%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₩324,000₩427,733₩430,000₩530,000
Change+21.80%+60.80%+61.65%+99.25%

Analyst Ratings

The average analyst rating for PharmaResearch stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy889999
Buy555566
Hold110000
Sell000000
Strong Sell000000
Total141414141515

Financial Forecast

Revenue This Year
677.40B
from 536.29B
Increased by 26.31%
Revenue Next Year
816.46B
from 677.40B
Increased by 20.53%
EPS This Year
16.64K
from 14.93K
Increased by 11.45%
EPS Next Year
21.41K
from 16.64K
Increased by 28.66%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
154.08B194.76B261.01B350.12B536.29B677.40B
Revenue Growth
41.69%26.40%34.02%34.14%53.18%26.31%
Gross Profit
108.33B141.51B190.26B251.24B411.22B517.68B
Gross Margin
70.31%72.66%72.89%71.76%76.68%76.42%
Operating Income
52.49B65.92B92.26B126.05B212.33B250.20B
Net Income
46.69B40.58B76.55B92.04B165.12B180.61B
EPS
----14,933.0016,643.21
EPS Growth
----67.02%11.45%
Forward PE
14.4910.9212.5522.0623.9615.98
Dividend / Share
600.00660.00950.001,100.003,700.004,263.43
Dividend Growth
20.00%10.00%43.94%15.79%236.36%15.23%
Free Cash Flow
----153.44B146.11B
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.

Revenue Forecast

Revenue202620272028
High681.4B
Avg677.4B
Low673.1B

Revenue Growth

Revenue Growth202620272028
High
27.1%
Avg
26.3%
Low
25.5%

EPS Forecast

EPS202620272028
High18,368.15
Avg16,643.21
Low15,756.00

EPS Growth

EPS Growth202620272028
High
23.0%
Avg
11.5%
Low
5.5%